Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Arena Names Executive Officer | Contract Pharma
Breaking News, Promotions & Moves

Arena Names Executive Officer

Audet to head operations and global regulatory affairs

Craig M. Audet has been appointed senior vice president of operations and head of global regulatory affairs at Arena Pharmaceuticals. Mr. Audet will also serve as an executive officer of the company.
 
Mr. Audet will oversee various operations, including investor relations and alliance management, and will continue to lead regulatory affairs. He joined the company in April 2011 as vice president of regulatory affairs, and has led interactions with the FDA and EMA for Belviq, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. The drug is currently under review by the EMA.
 
“This promotion recognizes Craig’s key role in the FDA’s approval of Belviq,” said Jack Lief, Arena’s president and chief executive officer. “We have benefited from his experience and track record of successful regulatory strategies and submissions, and we are delighted that he will play an expanded role in advancing Arena in the next phase of the company’s development.”
 
Mr. Audet has more than 25 years of industry experience. Prior to joining the company, he was vice president and head of the U.S. Regulatory Affairs Marketed Products Group at Sanofi-Aventis from 2003 to 2008, and was the cardiovascular global therapeutic area leader at Pfizer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters